Major Depressive Disorder (MDD) is increasingly recognised not solely as an affective disorder but also as one characterised by enduring cognitive impairments. These deficits, affecting domains such ...
In fall 2024, xanomeline trospium chloride (XT) was approved by the U.S. Food and Drug Administration for the treatment of adults with schizophrenia. In an earlier post, we reviewed evidence that this ...
The outcome of the 2024 U.S. presidential election, one of the most consequential in recent history, was determined in no small part by concerns about the cognitive state of President Biden and the ...